Results 91 to 100 of about 669 (138)

New targets for monitoring and therapy in Barth syndrome

open access: yes, 2016
Barth syndrome (BTHS), an X-linked disorder caused by defects in TAZ, is the only known single-gene disorder of cardiolipin remodeling. We hypothesized that through analysis of affected individuals, we would gain a better understanding of the range of ...
Dimitrios Avramopoulos   +15 more
core   +1 more source

Analysis of clinical and genetic characteristics of 18 pediatric patients with Barth syndrome

open access: yesShanghai Jiaotong Daxue xuebao. Yixue ban
Objective·To analyze the clinical and genetic characteristics of Chinese pediatric patients with Barth syndrome (BTHS) and provide data to support the prevention and treatment of BTHS.Methods·Eighteen pediatric patients diagnosed with BTHS at Shanghai ...
ZHAN Tianliu   +6 more
doaj   +1 more source

Corrigendum: Re-expression of tafazzin isoforms in TAZ-deficient C6 glioma cells restores cardiolipin composition but not proliferation rate and alterations in gene expression

open access: yesFrontiers in Genetics, 2022
Gayatri Jagirdar   +11 more
doaj   +1 more source

Quantitative and compositional study of cardiolipin in platelets by electrospray ionization mass spectrometry: application for the identification of Barth syndrome patients

open access: yes, 2002
BACKGROUND: The concentration of cardiolipin (CL) in cultured skin fibroblasts is a useful indicator of Barth syndrome (BTHS; MIM 302060), but the sampling and culturing of fibroblasts are burdensome and time-consuming procedures. We investigated whether
Valianpour, Fredoen   +4 more
core  

Insights into Neutrophil Dysfunction in Inherited Metabolic Disorders. [PDF]

open access: yesJ Innate Immun
Wolf A   +8 more
europepmc   +1 more source

A novel <i>TAFAZZIN</i> gene variant c.525_533del causing Barth syndrome and leading to heart transplantation: a case report. [PDF]

open access: yesFront Pediatr
Krawiec M   +9 more
europepmc   +1 more source

Metabolic cardiomyopathies: untangling clinical heterogeneity with human stem-cell derived models. [PDF]

open access: yesEMBO Mol Med
Passadouro AS   +6 more
europepmc   +1 more source

Granulopoietic Dysregulation in a Patient-Tailored Mouse Model of Barth Syndrome. [PDF]

open access: yesStem Cell Rev Rep
Sierra Potchanant EA   +12 more
europepmc   +1 more source

Adaptive mechanisms in pancreatic islets counteract mitochondrial dysfunction in Barth syndrome. [PDF]

open access: yesDiabetologia
Carlein C   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy